SEC Form 4 · accession 0001144204-18-042965
AVENUE THERAPEUTICS, INC. · ATXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Walter Vazzano
Officer — VP Finance & Corp. Controller
Period of report
Aug 7, 2018
Accepted (ET)
Aug 8, 2018 · 9:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001644963
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 7, 2018 | G | 30,000 | $0.00 | A | 61,351 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The 30,000 shares of restricted common stock will vest as follows: one-fourth on August 7, 2019, one-fourth on August 7, 2020, one-fourth on August 7, 2021, and one-fourth on August 7, 2022.